Zacks.com on MSN
Will Microsoft's $30B AI Build-Out Power Its Next Growth Phase?
MSFT ramps up $30B AI and cloud investments to expand Azure's global footprint and fuel its next growth phase.
NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, has re-filed an Abbreviated New Drug Application ("ANDA") for KETAFREE(TM), a preservative-free intravenous ("IV") ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback